0000899243-22-011461.txt : 20220317 0000899243-22-011461.hdr.sgml : 20220317 20220317185743 ACCESSION NUMBER: 0000899243-22-011461 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aguilar Richard CENTRAL INDEX KEY: 0001865481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39289 FILM NUMBER: 22750374 MAIL ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cano Health, Inc. CENTRAL INDEX KEY: 0001800682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 BUSINESS PHONE: 2034227700 MAIL ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 FORMER COMPANY: FORMER CONFORMED NAME: Jaws Acquisition Corp. DATE OF NAME CHANGE: 20200121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-15 0 0001800682 Cano Health, Inc. CANO 0001865481 Aguilar Richard CANO HEALTH, INC. 9725 NW 117TH AVENUE MIAMI FL 33178 0 1 0 0 Chief Clinical Officer Class A Common Stock 2022-03-15 4 A 0 171641 A 889870 D Stock Option (Right to Buy) 6.03 2022-03-15 4 A 0 37320 0.00 A 2032-03-15 Class A Common Stock 37320 37320 D These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31, 2022 and the remaining 50% of the RSUs vest on December, 31, 2023. The RSUs were granted on March 15, 2022. The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 15, 2023, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 15, 2022. /s/ David J. Armstrong, Attorney-in-Fact 2022-03-17